ZVSA
USDZyVersa Therapeutics Inc. Common Stock
$0.145+0.009 (6.618%)
Preço em tempo real
Healthcare
Biotecnologia
Estados Unidos
Gráfico de preços
Loading Chart...
Métricas-chave
Métricas de mercado
Abertura
$0.136
Máximo
$0.145
Mínimo
$0.136
Volume
0.00M
Fundamentos da empresa
Capitalização de mercado
1.2M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.04M
Bolsa de valores
OQB
Moeda
USD
Faixa de 52 semanas
Mínimo $0.11Atual $0.145Máximo $1.95
Notícias relacionadas
GlobeNewswire
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes
Type 2 diabetes (T2DM), affecting more than 530 million worldwide, is a metabolic disease often coupled with cardiovascular complications including coronary artery disease, heart failure, and stroke.Cardiovascular
Ver mais
GlobeNewswire
ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression
ZyVersa is developing Cholesterol Efflux Mediator™ VAR 200 to mediate removal of damaging excess cholesterol and other lipids from the kidneys' filtration system. VAR 200 directly removes lipids from kidney cells,
Ver mais
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.